Frankfurt - Delayed Quote EUR

Stevanato Group S.p.A. (87N.F)

21.20

+1.30

+(6.53%)

At close: May 9 at 9:55:01 PM GMT+2

Stevanato Group First Quarter 2025 Earnings: Beats Expectations

Stevanato Group ( NYSE:STVN ) First Quarter 2025 Results Key Financial Results Revenue: €256.6m (up 8.7% from 1Q 2024...

Simply Wall St. 23 hours ago

STVN
Stevanato Group to Participate in Upcoming Investor Conferences

PIOMBINO DESE, Italy, May 09, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced that it will participate in three upcoming investor conferences.

Business Wire yesterday

STVN
Stevanato Group SpA (STVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

Stevanato Group SpA (STVN) reports a 9% revenue increase, driven by high-value solutions, despite a decline in the Engineering segment.

GuruFocus.com 2 days ago

STVN
Stevanato Group (STVN) Q1 Earnings and Revenues Top Estimates

Stevanato (STVN) delivered earnings and revenue surprises of 10% and 0.23%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 3 days ago

STVN
Stevanato: Q1 Earnings Snapshot

PADUA, Italy (AP) — Stevanato Group SpA (STVN) on Thursday reported first-quarter profit of $27.9 million. On a per-share basis, the Padua, Italy-based company said it had profit of 11 cents. The results beat Wall Street expectations.

Associated Press Finance 3 days ago

STVN
Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025

PIOMBINO DESE, Italy, May 08, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the first quarter of 2025.

Business Wire 3 days ago

STVN
SDZNY vs. STVN: Which Stock Should Value Investors Buy Now?

SDZNY vs. STVN: Which Stock Is the Better Value Option?

Zacks 4 days ago

STVN
Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 200% and 4.93%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 5 days ago

HRTX

STVN
Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025

PIOMBINO DESE, Italy, April 24, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first quarter of 2025 on Thursday, May 8, 2025, at 6:30 a.m. (ET).

Business Wire 16 days ago

STVN
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

PIOMBINO DESE, Italy, March 11, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the KeyBanc Capital Markets Healthcare Forum taking place from Tuesday, March 18 to Wednesday, March 19, 2025.

Business Wire last month

STVN
Stevanato Group Full Year 2024 Earnings: In Line With Expectations

Stevanato Group ( NYSE:STVN ) Full Year 2024 Results Key Financial Results Revenue: €1.10b (up 1.7% from FY 2023). Net...

Simply Wall St. 2 months ago

STVN
Stevanato Group SpA (STVN) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

Stevanato Group SpA (STVN) reports steady revenue growth and strategic advancements despite margin pressures and industry challenges.

GuruFocus.com 2 months ago

STVN
Q4 2024 Stevanato Group SpA Earnings Call

Q4 2024 Stevanato Group SpA Earnings Call

Thomson Reuters StreetEvents 2 months ago

STVN
Stevanato Group (STVN) Meets Q4 Earnings Estimates

Stevanato (STVN) delivered earnings and revenue surprises of 0% and 1.85%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

STVN
Stevanato: Q4 Earnings Snapshot

The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for earnings of 20 cents per share. The maker of glass vials for COVID-19 vaccines posted revenue of $352.7 million in the period, surpassing Street forecasts.

Associated Press Finance 2 months ago

STVN
Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024

PIOMBINO DESE, Italy, March 06, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the fourth quarter and fiscal year 2024.

Business Wire 2 months ago

STVN
Stevanato Group S.p.A.'s (NYSE:STVN) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Stevanato Group (NYSE:STVN) has had a great run on the share market with its stock up by a significant 8.1% over the...

Simply Wall St. 2 months ago

STVN
Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025

PIOMBINO DESE, Italy, February 24, 2025--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that it will issue financial results for the fourth quarter and fiscal year 2024 on Thursday, March 6, 2025, at 6:30 a.m.(ET).

Business Wire 2 months ago

STVN
Stevanato Group S.p.A. (STVN): the Most Oversold Pharma Stock to Buy According to Analysts

We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to take a look at where Stevanato Group S.p.A. (NYSE:STVN) stands against the other oversold pharma stocks to buy according to analysts. On February 20, Emily Field, Head of European Pharma Research at […]

Insider Monkey 2 months ago

STVN
USNA or STVN: Which Is the Better Value Stock Right Now?

USNA vs. STVN: Which Stock Is the Better Value Option?

Zacks 2 months ago

STVN

USNA

Performance Overview

Return	87N.F	S&P 500 (^GSPC)
YTD	+3.92%	-3.77%
1-Year	-13.57%	+8.55%
3-Year	+64.51%	+41.81%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Stevanato Group S.p.A. (87N.F)

Stevanato Group First Quarter 2025 Earnings: Beats Expectations

Stevanato Group to Participate in Upcoming Investor Conferences

Stevanato Group SpA (STVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

Stevanato Group (STVN) Q1 Earnings and Revenues Top Estimates

Stevanato: Q1 Earnings Snapshot

Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025

SDZNY vs. STVN: Which Stock Should Value Investors Buy Now?

Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates

Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

Stevanato Group Full Year 2024 Earnings: In Line With Expectations

Stevanato Group SpA (STVN) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

Q4 2024 Stevanato Group SpA Earnings Call

Stevanato Group (STVN) Meets Q4 Earnings Estimates

Stevanato: Q4 Earnings Snapshot

Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024

Stevanato Group S.p.A.'s (NYSE:STVN) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025

Stevanato Group S.p.A. (STVN): the Most Oversold Pharma Stock to Buy According to Analysts

USNA or STVN: Which Is the Better Value Stock Right Now?

Performance Overview